• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Bcl-2 家族与 Ras 家族小 GTPases 之间的串扰:潜在的细胞命运调控?

Crosstalk between Bcl-2 family and Ras family small GTPases: potential cell fate regulation?

机构信息

ROS, Apoptosis and Cancer Biology Laboratory, Department of Physiology, Yong Loo Lin School of Medicine Singapore, Singapore ; NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore Singapore, Singapore.

出版信息

Front Oncol. 2013 Jan 2;2:206. doi: 10.3389/fonc.2012.00206. eCollection 2012.

DOI:10.3389/fonc.2012.00206
PMID:23316476
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3539672/
Abstract

Cell fate regulation is a function of diverse cell signaling pathways that promote cell survival and or inhibit cell death execution. In this regard, the role of the Bcl-2 family in maintaining a tight balance between cell death and cell proliferation has been extensively studied. The conventional dogma links cell fate regulation by the Bcl-2 family to its effect on mitochondrial permeabilization and apoptosis amplification. However, recent evidence provide a novel mechanism for death regulation by the Bcl-2 family via modulating cellular redox metabolism. For example overexpression of Bcl-2 has been shown to contribute to a pro-oxidant intracellular milieu and down-regulation of cellular superoxide levels enhanced death sensitivity of Bcl-2 overexpressing cells. Interestingly, gene knockdown of the small GTPase Rac1 or pharmacological inhibition of its activity also reverted death phenotype in Bcl-2 expressing cells. This appears to be a function of an interaction between Bcl-2 and Rac1. Similar functional associations have been described between the Bcl-2 family and other members of the Ras superfamily. These interactions at the mitochondria provide novel opportunities for strategic therapeutic targeting of drug-resistant cancers.

摘要

细胞命运的调节是多种细胞信号通路的功能,这些信号通路促进细胞存活和/或抑制细胞死亡执行。在这方面,Bcl-2 家族在维持细胞死亡和增殖之间的紧密平衡方面的作用已经得到了广泛的研究。传统观点将 Bcl-2 家族通过调节线粒体通透性和凋亡放大来调节细胞命运与凋亡联系起来。然而,最近的证据提供了一种通过调节细胞氧化还原代谢来调节死亡的新机制。例如,Bcl-2 的过表达已被证明有助于产生促氧化的细胞内环境,而细胞内超氧水平的下调增强了 Bcl-2 过表达细胞的死亡敏感性。有趣的是,小 GTPase Rac1 的基因敲低或其活性的药理学抑制也使 Bcl-2 表达细胞的死亡表型恢复正常。这似乎是 Bcl-2 与 Rac1 之间相互作用的一种功能。Bcl-2 家族和 Ras 超家族的其他成员之间也描述了类似的功能关联。这些在线粒体的相互作用为耐药性癌症的战略治疗靶向提供了新的机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3491/3539672/0a49df6590ac/fonc-02-00206-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3491/3539672/0a49df6590ac/fonc-02-00206-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3491/3539672/0a49df6590ac/fonc-02-00206-g001.jpg

相似文献

1
Crosstalk between Bcl-2 family and Ras family small GTPases: potential cell fate regulation?Bcl-2 家族与 Ras 家族小 GTPases 之间的串扰:潜在的细胞命运调控?
Front Oncol. 2013 Jan 2;2:206. doi: 10.3389/fonc.2012.00206. eCollection 2012.
2
Cross Talk Between Cellular Redox State and the Antiapoptotic Protein Bcl-2.细胞氧化还原状态与抗凋亡蛋白 Bcl-2 之间的串扰。
Antioxid Redox Signal. 2018 Nov 1;29(13):1215-1236. doi: 10.1089/ars.2017.7414. Epub 2018 Feb 15.
3
Overexpression of Bcl-2 induces STAT-3 activation via an increase in mitochondrial superoxide.Bcl-2的过表达通过增加线粒体超氧化物来诱导STAT-3激活。
Oncotarget. 2015 Oct 27;6(33):34191-205. doi: 10.18632/oncotarget.5763.
4
The anti-oxidant and pro-oxidant dichotomy of Bcl-2.Bcl-2的抗氧化与促氧化二分法
Biol Chem. 2016 Jul 1;397(7):585-93. doi: 10.1515/hsz-2016-0127.
5
The small GTPase Rac1 is a novel binding partner of Bcl-2 and stabilizes its antiapoptotic activity.小分子 GTP 酶 Rac1 是 Bcl-2 的一个新的结合伴侣,并稳定其抗凋亡活性。
Blood. 2011 Jun 9;117(23):6214-26. doi: 10.1182/blood-2010-08-301283. Epub 2011 Apr 7.
6
Regulation of mitochondrial metabolism: yet another facet in the biology of the oncoprotein Bcl-2.调控线粒体代谢:癌蛋白 Bcl-2 生物学的又一特点。
Biochem J. 2011 May 1;435(3):545-51. doi: 10.1042/BJ20101996.
7
Bcl-2: a prime regulator of mitochondrial redox metabolism in cancer cells.Bcl-2:癌细胞中线粒体氧化还原代谢的主要调节因子。
Antioxid Redox Signal. 2011 Dec 15;15(12):2975-87. doi: 10.1089/ars.2010.3851. Epub 2011 Jul 12.
8
Opposing roles of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase in the cellular response to ionizing radiation in human cervical cancer cells.c-Jun氨基末端激酶和p38丝裂原活化蛋白激酶在人宫颈癌细胞对电离辐射的细胞反应中的相反作用
Mol Cancer Res. 2008 Nov;6(11):1718-31. doi: 10.1158/1541-7786.MCR-08-0032.
9
Modulating mitochondria-mediated apoptotic cell death through targeting of Bcl-2 family proteins.通过靶向Bcl-2家族蛋白来调节线粒体介导的凋亡细胞死亡。
Recent Pat DNA Gene Seq. 2007;1(1):43-61. doi: 10.2174/187221507779814434.
10
R-Ras promotes apoptosis caused by growth factor deprivation via a Bcl-2 suppressible mechanism.R-Ras通过一种Bcl-2可抑制的机制促进生长因子剥夺所引起的细胞凋亡。
J Cell Biol. 1995 May;129(4):1103-14. doi: 10.1083/jcb.129.4.1103.

引用本文的文献

1
Remodeling of intracellular architecture during SARS-CoV-2 infection of human endothelium.在 SARS-CoV-2 感染人类内皮细胞期间细胞内结构的重塑。
Sci Rep. 2024 Nov 30;14(1):29784. doi: 10.1038/s41598-024-80351-z.
2
In-depth analysis of the interplay between oncogenic mutations and NK cell-mediated cancer surveillance in solid tumors.深入分析致癌突变与 NK 细胞介导的实体瘤中肿瘤监视之间的相互作用。
Oncoimmunology. 2024 Jul 18;13(1):2379062. doi: 10.1080/2162402X.2024.2379062. eCollection 2024.
3
Bcl-2 dependent modulation of Hippo pathway in cancer cells.

本文引用的文献

1
A review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia.探讨 Puma、Noxa 和 Bim 在慢性淋巴细胞白血病的肿瘤发生、治疗和耐药中的作用。
Cancer Gene Ther. 2013 Jan;20(1):1-7. doi: 10.1038/cgt.2012.84. Epub 2012 Nov 23.
2
Targeting the Bcl-2 family for cancer therapy.针对 Bcl-2 家族进行癌症治疗。
Expert Opin Ther Targets. 2013 Jan;17(1):61-75. doi: 10.1517/14728222.2013.733001. Epub 2012 Nov 22.
3
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance.
Bcl-2 依赖性调节癌细胞中的 Hippo 通路。
Cell Commun Signal. 2024 May 16;22(1):277. doi: 10.1186/s12964-024-01647-1.
4
PTPσ inhibitors promote hematopoietic stem cell regeneration.PTPσ 抑制剂促进造血干细胞再生。
Nat Commun. 2019 Aug 14;10(1):3667. doi: 10.1038/s41467-019-11490-5.
5
Perspectives of RAS and RHEB GTPase Signaling Pathways in Regenerating Brain Neurons.RAS 和 RHEB GTPase 信号通路在再生脑神经元中的作用。
Int J Mol Sci. 2018 Dec 14;19(12):4052. doi: 10.3390/ijms19124052.
6
Inferring gene and protein interactions using PubMed citations and consensus Bayesian networks.利用PubMed文献引用和共识贝叶斯网络推断基因与蛋白质的相互作用。
PLoS One. 2017 Oct 19;12(10):e0186004. doi: 10.1371/journal.pone.0186004. eCollection 2017.
7
Subcellular Distribution of S-Nitrosylated H-Ras in Differentiated and Undifferentiated PC12 Cells during Hypoxia.缺氧期间分化和未分化的PC12细胞中S-亚硝基化H-Ras的亚细胞分布
Cell J. 2017 Oct;19(3):443-451. doi: 10.22074/cellj.2017.4546. Epub 2017 Aug 19.
8
Antitumor effects of minodronate, a third-generation nitrogen-containing bisphosphonate, in synergy with γδT cells in human glioblastoma in vitro and in vivo.第三代含氮双膦酸盐米诺膦酸与人γδT细胞协同对人胶质母细胞瘤的体内外抗肿瘤作用
J Neurooncol. 2016 Sep;129(2):231-41. doi: 10.1007/s11060-016-2186-x. Epub 2016 Jul 8.
9
The Tumor-suppressive Small GTPase DiRas1 Binds the Noncanonical Guanine Nucleotide Exchange Factor SmgGDS and Antagonizes SmgGDS Interactions with Oncogenic Small GTPases.肿瘤抑制性小GTP酶DiRas1与非经典鸟嘌呤核苷酸交换因子SmgGDS结合,并拮抗SmgGDS与致癌性小GTP酶的相互作用。
J Biol Chem. 2016 Mar 18;291(12):6534-45. doi: 10.1074/jbc.M115.696831. Epub 2016 Jan 26.
10
Mitochondrial Proteins (e.g., VDAC, Bcl-2, HK, ANT) as Major Control Points in Oncology.线粒体蛋白(如电压依赖性阴离子通道蛋白、B细胞淋巴瘤-2蛋白、己糖激酶、腺嘌呤核苷酸转位酶)作为肿瘤学中的主要控制点
Front Oncol. 2014 Dec 15;4:365. doi: 10.3389/fonc.2014.00365. eCollection 2014.
Ras/Raf/MEK/ERK和PI3K/PTEN/Akt/mTOR级联抑制剂:突变如何导致治疗耐药以及如何克服耐药
Oncotarget. 2012 Oct;3(10):1068-111. doi: 10.18632/oncotarget.659.
4
[TOR-centric concept of regulation mitogenic, metabolic and energetic signal processing in cell].[细胞中以TOR为中心的促有丝分裂、代谢和能量信号处理调控概念]
Tsitologiia. 2012;54(8):589-602.
5
Approaches to Ras signaling modulation and treatment of Ras-dependent disorders: a patent review (2007--present).针对 Ras 信号转导的调控及 Ras 依赖性疾病治疗方法的专利研究进展(2007 年至今)
Expert Opin Ther Pat. 2012 Nov;22(11):1263-87. doi: 10.1517/13543776.2012.728586. Epub 2012 Sep 26.
6
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response.Ras/Raf/MEK/ERK和PI3K/PTEN/Akt/mTOR信号通路的突变和失调会改变治疗反应。
Oncotarget. 2012 Sep;3(9):954-87. doi: 10.18632/oncotarget.652.
7
SIRT1 promotes thyroid carcinogenesis driven by PTEN deficiency.SIRT1 促进了由 PTEN 缺失驱动的甲状腺癌发生。
Oncogene. 2013 Aug 22;32(34):4052-6. doi: 10.1038/onc.2012.407. Epub 2012 Sep 17.
8
PI3K pathway inhibitors: better not left alone.PI3K 通路抑制剂:最好不要单独使用。
Curr Pharm Des. 2013;19(5):895-906.
9
Ras oncogenes in oral cancer: the past 20 years.口腔癌中的 Ras 癌基因:过去 20 年的研究进展
Oral Oncol. 2012 May;48(5):383-92. doi: 10.1016/j.oraloncology.2011.12.006. Epub 2012 Jan 11.
10
A palmitoylation switch mechanism regulates Rac1 function and membrane organization.棕榈酰化开关机制调节 Rac1 功能和膜组织。
EMBO J. 2012 Feb 1;31(3):534-51. doi: 10.1038/emboj.2011.446. Epub 2011 Dec 9.